Skip to content

Study on markers related to the outcome of neurological function in patients with acute ischemic stroke after endovascular treatment

Study on markers related to the outcome of neurological function in patients with acute ischemic stroke after endovascular treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074368
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Good Prognosis Group:No intervention
Poor Prognosis Group:No intervention

Sponsors

Department of Neurology, Ganzhou People's Hospital (Ganzhou Hospital affiliated to Nanchang University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Signed the informed consent voluntarily; went to Ganzhou People's Hospital(Ganzhou Hospital affiliated to Nanchang University) from August 2023 to December 2030, referring to the Guidelines for Early endovascular Intervention of Acute Ischemic Stroke in China 2018, and planned to undergo endovascular treatment according to the medical advice after diagnosis and clinical decision.

Exclusion criteria

Exclusion criteria: History or evidence of cerebral hemorrhage, subarachnoid hemorrhage, craniocerebral trauma, mental illness, arteriovenous malformation, cerebral aneurysms or brain tumor;Acute ST segment elevation myocardial infarction, and / or acute decompensated heart failure, and / or QT terval> 520ms, and / or a known history of cardiac arrest (no pulse electrical activity, ventricular tachycardia, ventricular fibrillation, cardiac arrest), and / or admission for acute coronary syndrome, myocardial infarction, or coronary intervention (percutaneous coronary intervention or coronary surgery) in the past 3 months;Patients with complicated autoimmune diseases, blood diseases or malignant tumors;Baseline platelet count <50,000 / UL;Suspected infectious emboli or suspected bacterial endocarditis;gravida;The physician judged that the patient had poor compliance and expected follow-up.

Design outcomes

Primary

MeasureTime frame
90 day mRS scale;

Secondary

MeasureTime frame
VILIP-1;serious brain edema;Hemorrhagic transformation;neuron-specific enolase;

Countries

China

Contacts

Public ContactGuoyong Zeng

Ganzhou People's Hospital (Ganzhou Hospital affiliated to Nanchang University)

hsyygy@163.com+86 135 0707 9530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026